2019-11-11T09:55:29-06:00 2018-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2018-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 3025 CHEMICAL ROAD NO 100 PLYMOUTH MEETING PA 19462 EILEEN BOSCIA CHIEF FINANCAL OFFICER 2156900300 2019-10-24 1 JOSEPH M KISTNER CPA P00157086 2674403000 100.11.134.178 2019-10-24 14:44:32 ED P 7BB29012DECEEFDF62CFC2E5312F19906E6D7D23 F061244EAF8291A5AD75BBECB28DE81C43B57F33 2018 2020-04-17 16:48:07Z X ROBERT W CARLSON MD 3025 CHEMICAL ROAD NO 100 PLYMOUTH MEETING PA 19462 35852278 0 X WWW.NCCN.ORG X 1993 DE TO IMPROVE AND FACILITATE QUALITY, EFFECTIVE, EFFICIENT, AND ACCESSIBLE CANCER CARE SO PATIENTS CAN LIVE BETTER LIVES. 28 28 126 1359 241785 138061 17844586 16587411 15819880 17540902 147091 468733 879442 1255232 34690999 35852278 1774075 1772971 0 0 15518284 16451800 0 0 651670 9571673 10049474 26864032 28274245 7826967 7578033 56114451 62710370 17046656 16084194 39067795 46626176 X TO IMPROVE AND FACILITATE QUALITY, EFFECTIVE, EFFICIENT, AND ACCESSIBLE CANCER CARE SO PATIENTS CAN LIVE BETTER LIVES. 0 0 13643684 16014202 WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE. 3180227 1501117 DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ACCESS THE QUALITY OF CARE. 3129276 1772971 DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE THE STATE-OF-THE-ART IN CANCER CARE. 2930099 1280815 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 2930099 1280815 22883286 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 266 0 1 126 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 28 28 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X EILEEN BOSCIA 2156900300 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 JAN C BUCKNER MD DIRECTOR, VICE CHAIR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR, CHAIR 2.00 X 0 0 0 LORI C PICKENS MHA DIRECTOR, SECRETARY 2.00 X 0 0 0 DOROTHY E PUHY MBA DIRECTOR, TREASURER 2.00 X 0 0 0 ROBERT H VONDERHEIDE MD DPHIL DIRECTOR 2.00 X 0 0 0 MATT KALAYCIO MD DIRECTOR 2.00 X 0 0 0 RAVI SALGIA MD PHD DIRECTOR 2.00 X 0 0 0 THOMAS A D'AMICO MD DIRECTOR 2.00 X 0 0 0 RICHARD I FISHER MD DIRECTOR 2.00 X 0 0 0 KENNETH H COWAN MD PHD DIRECTOR 2.00 X 0 0 0 F MARC STEWART MD DIRECTOR 2.00 X 0 0 0 JOHN W SWEETENHAM MD FACP FRCP DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 LOUIS B HARRISON MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 STEPHEN B EDGE MD FACS FASCO DIRECTOR 2.00 X 0 0 0 ALBERTO S PAPPO MD DIRECTOR 2.00 X 0 0 0 EBEN L ROSENTHAL MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 STEVEN J FRANK MD DIRECTOR 2.00 X 0 0 0 BARBARA PARKER MD DIRECTOR 2.00 X 0 0 0 ALAN P VENOOK MD DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 W THOMAS PURCELL MD MBA DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR 2.00 X 0 0 0 RUTH M O'REGAN MD DIRECTOR 2.00 X 0 0 0 MADAN H JAGASIA MD MBBS MMHC MS DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 40.00 X 840624 0 65845 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 X 458036 0 71944 LISA G KIMBRO CHIEF FINANCIAL OFFICER 40.00 X 229322 0 46121 WUI-JIN KOH CHIEF MEDICAL OFFICER 40.00 X 160404 0 2074 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 40.00 X 216683 0 39780 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 40.00 X 296480 0 65967 KRISTINA M GREGORY VP, CLINICAL INFORMATION OPERATIONS 40.00 X 249204 0 37252 LINDA LEACH VP, ADMIN. & HUMAN RESOURCES 40.00 X 231289 0 35583 EILEEN BOSCIA CONTROLLER 40.00 X 187602 0 25373 SUSAN MOST DIRECTOR, CLINICAL OPERATI 40.00 X 175813 0 35080 JENNIFER TREDWELL SENIOR DIRECTOR, MARKETING 40.00 X 152771 0 57000 3198228 0 482019 35 0 1 0 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION PROGRAM SERVICES 1369099 ADVANCED MICRO COMPUTER SPEC 5100 CAMPUS DRIVE SUITE 140 PLYMOUTH MEETING PA 19462 PROFESSIONAL SERVICES 381181 MORGAN LEWIS & BOCKIUS LLP PO BOX 8500 S-6050 PHILADELPHIA PA 19178 LEGAL 362757 ALCOM PRINTING GROUP INC 140 CHRISTOPHER LANE HARLEYSVILLE PA 19438 FULFILLMENT - SHIPPING & POSTAGE 330216 DANA FARBERPARTNERS CANCERCAR 44 BINNEY ST BP 320 BOSTON MA 02115 RESEARCH 329343 23 3544167 13043244 16587411 LICENSE FEES 900099 6161825 6161825 PERMISSION FEES 900099 4104341 4104341 GUIDELINE DISTRIBUTION 900099 2051757 2051757 SUBSCRIPTIONS 900099 1521427 1521427 3701552 3701552 17540902 468733 468733 1013447 1013447 ADVERTISING 541800 241785 241785 241785 35852278 18554349 241785 468733 1772971 1772971 2201550 1669402 475132 57016 10120046 9028726 673267 418053 650706 565514 60127 25065 2703776 2349795 249834 104147 775722 674164 71678 29880 369020 271115 97905 67050 13500 53550 867329 552526 314803 143195 99931 43264 305782 233608 72154 20 616443 382308 234127 8 1301034 1301034 1501654 1229677 259572 12405 2310678 2310678 319393 319393 145824 2464 143360 HONORARIA 509037 507037 2000 CATERING 443663 367178 76038 447 PRINTING AND PUBLICATIO 309364 295654 13710 A/V EXPENSES 274809 241212 33407 190 565199 315826 244934 4439 28274245 22883286 4739289 651670 33170246 10616100 15875047 42859104 3553744 4939880 1860885 1227307 524928 41562 683498 533746 4444243 1951572 446103 2492671 56114451 62710370 2302392 2486836 14744264 13597358 17046656 16084194 X 33868986 42568945 5198809 4057231 39067795 46626176 56114451 62710370 7578033 -19652 0 X X 0 1 X 1 0 X 16954382 16644006 17007659 17844586 16587411 85038044 16954382 16644006 17007659 17844586 16587411 85038044 3836079 81201965 547109 546617 584784 835319 1482180 3996009 80716 117219 93650 86428 139061 517074 10237397 11748410 14874838 15819880 17540902 70221427 159772554 0.50820 0.51560 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: GUIDELINE DISTRIBUTION $2,051,757 PERMISSION FEES 4,104,341 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 1,521,427 LICENSE FEE REVENUE FOR LICENSING OF NCCN PRODUCTS 6,161,825 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 401,405 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 276,800 TUITION FEES FOR NCCN ACADEMY 826,802 ACCESS FEES FOR NCCN CONTENT 121,714 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 760,000 CONSULTING REVENUE 860,818 FELLOWSHIP GRANT 454,013 TOTAL $17,540,902 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9851 9851 28264394 28274245 1000000 250000 0 0 1000000 1000000 1500000 9851 9851 250000 250000 375000 SCHEDULE C PART II-A, LINE 1 LOBBYING EXPENDITURES ON PART II-A, LINE 1 OF $9,851 INCLUDE STAFF TIME ASSOCIATED WITH LOBBYING ACTIVITIES INCLUDING CANCER CARE PLANNING AND COMMUNICATIONS ACT, DISCUSSION OF HEALTH REFORM, LIFETIME LIMITS AND PRE-EXISTING CONDITIONS, SENDING LETTERS TO SUBCOMMITTEES ON HEALTH, ADDICTION PREVENTION AND RESPONSIBLE OPIOID PRACTICES ACT, CAR T CONGRESSIONAL BRIEFING, MODERN LABELING ACT, CLINICAL TREATMENT ACT AS WELL AS TRAVEL FOR HILL DAYS IN WASHINGTON DC AND DUES ASSOCIATED WITH LOBBYING ACTIVITY. 1165703 23790 1141913 3278540 1927782 1350758 2492671 35832626 -19652 -19652 35852278 0 35852278 28274245 0 28274245 0 28274245 EUROPE 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM 91529 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 59826 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM 35293 0 0 0 0 0 0 186648 0 186648 0 0 0 0 0 0 SCHEDULE F - PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVE CLEVELAND OH 44106 341018992 501(C)(3) 35000 RESEARCH CITY OF HOPE COMP CANCER CTR 1500 E DUARTE RD DUARTE CA 91010 951683875 501(C)(3) 21393 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 488415 RESEARCH DUKE UNIVERSITY 3100 TOWER BLVD STE 1300 DURHAM NC 27707 560532129 501(C)(3) 33016 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501(C)(3) 9336 RESEARCH HEALTH RESEARCH INC ROSEWELL PARK CANCER CENTER - ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 265518 RESEARCH JOHNS HOPKINS UNIVERSITY 733 N BROADWAY SUITE 117 BALTIMORE MD 21205 520595110 501(C)(3) 29496 RESEARCH MAYO CLINIC 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501(C)(3) 5946 RESEARCH NORTHWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 64078 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43221 316401599 501(C)(3) 51979 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET ROOM 425 SAN FRANCISCO CA 94143 946036493 501(C)(3) 30833 RESEARCH REGENTS OF UNIV OF CO DENVER 1800 GRANT ST 800 DENVER CO 80203 846000555 501(C)(3) 115150 RESEARCH TEXAS A&M HEALTH SCIENCE CTR 400 HARVEY MITCHELL PARKWAY SOUTH SUITE 300 COLLEGE STATION TX 77845 742907553 1589 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE AVE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 309273 RESEARCH UNIVERSITY OF NEBRASKA MEDICAL CENTER 985100 NEBRASKA MEDICAL CENTER OMAHA NE 681985100 470049123 501(C)(3) 12021 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ROOM 2044 ANN ARBOR MI 48104 386006309 501(C)(3) 86245 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATTLE WA 98109 916001537 115 118082 RESEARCH WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE ST LOUIS MO 63112 430653611 501(C)(3) 63873 RESEARCH YALE UNIVERSITY 100 CHURCH STREET SOUTH SUITE A160 NEW HAVEN CT 06520 060646973 501(C)(3) 31728 RESEARCH 18 1 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS OR THEIR INSTITUTIONS MUST ATTEST THAT THEY WILL ABIDE BY THE TERMS OF NCCN RESEARCH AGREEMENTS AND THAT THE PRINCIPAL INVESTIGATORS HAVE NOT BEEN DISBARRED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN THE REQUIRED TIMELINE, NCCN MAY REQUEST THE INVESTIGATOR SUBMIT A CORRECTIVE ACTION PLAN FOR NCCN'S APPROVAL OR TERMINATE THE STUDY. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A MONTHLY OR QUARTERLY BASIS THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF TOTAL ENROLLMENT, ELIGIBILITY, AND ACCRUAL OF PATIENTS. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARKS FOR PATIENT ACCRUAL ARE MET AND THE FINAL PAYMENT IS DISBURSED UPON RECEIPT OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS THAT DO NOT ENROLL THEIR STUDIES FULLY ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 716923 0 123701 0 0 0 27500 0 38345 0 906469 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 417867 0 40169 0 0 0 27500 0 44444 0 529980 0 0 0 LISA G KIMBRO CHIEF FINANCIAL OFFICER 198921 0 30401 0 0 0 20473 0 25648 0 275443 0 0 0 WUI-JIN KOH CHIEF MEDICAL OFFICER 160404 0 0 0 0 0 0 0 2074 0 162478 0 0 0 JOAN S MCCLURE SENIOR VP, CLINICAL INFORM 186504 0 30179 0 0 0 19112 0 20668 0 256463 0 0 0 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 269314 0 27166 0 0 0 27500 0 38467 0 362447 0 0 0 KRISTINA M GREGORY VP, CLINICAL INFORMATION OPERATIONS 227460 0 21744 0 0 0 23045 0 14207 0 286456 0 0 0 LINDA LEACH VP, ADMIN. & HUMAN RESOURCES 210489 0 20800 0 0 0 21376 0 14207 0 266872 0 0 0 EILEEN BOSCIA CONTROLLER 170468 0 17134 0 0 0 11265 0 14108 0 212975 0 0 0 SUSAN MOST DIRECTOR, CLINICAL OPERATI 161629 0 14184 0 0 0 10860 0 24220 0 210893 0 0 0 JENNIFER TREDWELL SENIOR DIRECTOR, MARKETING 148114 0 4657 0 0 0 10231 0 46769 0 209771 0 0 0 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,359 VOLUNTEERS COMMIT APPROXIMATELY 31,134 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11B NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2017. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B: THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF MEDICAL OFFICER, CHIEF FINANCIAL OFFICER (CFO), AND SENIOR VICE PRESIDENT U.S. & GLOBAL DEVELOPMENT IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2017. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 NCCN FOUNDATION L 797347 FMV NCCN FOUNDATION O 666466 FMV NCCN FOUNDATION P 153216 FMV PART V LINE 2, COLUMN C PROFESSIONAL FEES $73,590 TRAVEL AND MEETINGS 51,077 OFFICE EXPENSE 6,855 SUPPLIES AND PRINTING 3,048 OTHER EXPENSES 10,850 MARKETING AND PUBLIC RELATIONS 5,727 TELEPHONE 2,069 TOTAL $153,216